SciELO - Scientific Electronic Library Online

 
vol.8 número4Simulação Clínica: Formação e Inovação na Promoção da Qualidade e Segurança do DoenteImpacto da Demonstração Repetida na Técnica Inalatória: Um Estudo Intervencional Prospetivo índice de autoresíndice de assuntosPesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Gazeta Médica

versão impressa ISSN 2183-8135versão On-line ISSN 2184-0628

Gaz Med vol.8 no.4 Queluz dez. 2021  Epub 01-Fev-2022

https://doi.org/10.29315/gm.v8i4.497 

Artigo Original

Osteomyelitis in a General Pediatric Ward

Osteomielites num Serviço de Pediatria Geral

1. Pediatric Service, Hospital Vila Franca de Xira, Vila Franca de Xira, Portugal.

2. Department of Pediatrics, Hospital Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisboa, Portugal.

3. Orthopedic Service, Hospital Vila Franca de Xira, Vila Franca de Xira, Portugal.


Abstract

Introduction:

Pediatric acute osteomyelitis (AO) is a serious condition and a challenging diagnosis. It mainly affects previously healthy individuals and Staphylococcus aureus is the leading causative agent. The objective of this study was to characterize all pediatric AO cases admitted to a second-level hospital during a six-year period.

Methods:

Retrospective single-center study, including all children under 18 years-old with a primary diagnosis of AO. Descriptive statistics analysis was performed.

Results:

Ten cases were identified, 60% males. The median age was 6.7 years. Previous trauma was referred by five. Affected locations were foot (n=3), tibia (n=3), femur (n=2), sacrum (n=1) and hand (n=1). All presented with local pain and limping or inability to walk (except one case with hand involvement). Four patients had fever and inflammatory signs, namely erythema and edema, were reported by four. At admission, nine had elevated inflammatory markers and six out of eight had normal radiographs. Magnetic resonance imaging confirmed the diagnosis in seven. Blood cultures were positive for Staphylococcus aureus (n=3) and Streptococcus pyogenes (n=1). Salmonella enteritidis was isolated from pus (n=1) and there was one presumed Kingella kingae AO defined as a positive polymerase chain reaction test from an oropharyngeal swab. The average duration of parenteral and oral antibiotherapy was 14.7 days 3.9 weeks, respectively. The antibiotic of choice was flucloxacillin. Two patients developed local complications.

Discussion:

An unspecific and subacute clinical and radiological presentation together with low positive blood culture rates difficults timely diagnosis and management. An early empirical parenteral antibiotherapy is mandatory, followed by an oral regimen for at least four weeks.

Keywords: Child; Osteomyelitis/diagnosis; Osteomyelitis/therapy

Resumo

Introdução:

A osteomielite aguda (OA) é uma patologia grave e desafiante. Ocorre sobretudo em indivíduos saudáveis e o Staphylococcus aureus é o principal agente. O objetivo deste estudo foi caracterizar os casos de OA pediátricos admitidos num hospital nível-dois durante um período de 6 anos.

Métodos:

Estudo retrospetivo incluindo todas as crianças com idade inferior a 18 anos com OA como diagnóstico primário. Foi realizada análise estatística descritiva.

Resultados:

Dez casos foram identificados, 60% rapazes. Média de idades de 6,7 anos. A história de trauma anterior foi referida por cinco. Os locais afetados foram o pé (n=3), tíbia (n=3), fémur (n=2), sacro (n=1) e mão (n=1). Todos se apresentaram com dor local e alteração da marcha (recusa ou claudicação), exceto um com afeção da mão. Quatro doentes tinham febre e a presença de sinais inflamatórios, como eritema ou edema, foi reportada em quatro doentes. À admissão, nove tinham elevação de parâmetros inflamatórios e seis em 8 tinham radiografia sem alterações. A ressonância magnética permitiu o diagnóstico em sete. Hemoculturas positivas para Staphylococcus aureus (n=3) e Streptococcus pyogenes (n=1). Salmonella enteritidis foi isolada no pus (n=1) e diagnóstico presuntivo de AO por Kingella kingae, identificada por reação de polimerase em cadeia numa amostra da orofaringe. Antibioticoterapia empírica parentérica foi cumprida em média por 14,7 dias e oral por 3,9 semanas. O antibiótico de escolha foi a flucloxacilina. Dois pacientes desenvolveram complicações locais.

Discussão:

A apresentação clínica e radiológica subaguda e inespecífica associada à baixa taxa de hemoculturas positivas dificultam o diagnóstico e tratamento. O início precoce de antibioticoterapia empírica parentérica é mandatório, seguido de tratamento por via oral pelo menos 4 semanas.

Palavras-chave: Criança; Osteomielite/diagnóstico; Osteomielite/tratamento

Introduction

Acute osteomyelitis (AO) is a bacterial infection of the bone that can evolve to its destruction. Paediatric prevalence has remained stable over the last decades, with an estimated rate of 1/5000 under 13 years old.1 Its global incidence is 0.2-1.6/1000, varying significantly across the world.2 About 50% of cases occur under five years of age due to the richer metaphyseal blood supply and immature immune system.1,3-5 Boys are 1.5-2 times more likely to be affected than girls.1,3,6,7

Bacteremia is the most common pathophysiologic mechanism. One-third of the patients have a history of recent trauma.1,6 Some risk factors associated with AO are sickle cell disease, diabetes mellitus, chronic renal disease, varicella infection and immunodeficiency.1,6 However, most of the cases occur in previously healthy individuals.

Long tubular bones are affected in more than 80% of AO, particularly the femur and the tibia.4,8 Bacteria reach the bone through the nutrient artery and lodge and multiply at the metaphyseal capillaries’ loops, favored by its turbulent flow.3,4 The most affected nontubular bones are the calcaneus and pelvic region.8

The usual responsible microorganisms are oropharynx colonizers, namely Staphylococcus aureus (S. aureus) and Streptococcus pyogenes (S. pyogenes), with an age-dependent relative frequency.3Kingella kingae (K. kingae) plays a major role in children under four years old.3,5,9 In a recent systematic review, Maria Wong et al10 found a 30.8% prevalence of K. kingae osteoarticular infections in the paediatric population, with a significant increase under 48 months of age (47.6%).10 Considering children with hemoglobinopathies SS or SC and those in developing countries, Salmonella species are an important cause of AO.3,5,7,11 Neonatal AO has a broader group of potential causative microorganisms, such as Streptococcus agalactiae, coagulase-negative Staphylococci and Enterobacteriaceae.3,5

The hallmark of AO is localized pain and impaired function.5 Diagnosis depends on clinical history, physical examination, laboratory tests, imaging, and microorganism isolation from the site of infection or blood.3

The objective of this study was to describe and characterize AO cases admitted to the pediatric ward of a second-level hospital in a six-year period (2014-2019).

Methods

A retrospective single-center study was conducted, including all the children under 18 years old with a primary diagnosis of AO admitted to our hospital. Clinical information was obtained by consulting medical records. Free and informed consent was signed by parents or legal representative. Descriptive statistics analysis was performed using Microsoft® Excel 2018.

Results

Ten AO cases were identified, six boys and four girls. The median age was 6.7 years ENT#091;1.7-13ENT#093;. Forty percent were younger than five years old and all were previously healthy. A recent history of a direct trauma was reported by 50% of the patients, which occurred 8.4 ± 11.3 days before admission. A dog bite to the hand from an adequately vaccinated family dog was reported, with no microbiological agent identified.

Local pain was referred by all the patients and impaired function or refusal to walk by nine (100% if lower limb affected). Three presented with local swelling and one with erythema. Four children had fever and only two of those exhibited the signs of inflammation mentioned above. The lower limbs were the most affected (80%): foot (n=3), tibia (n=3) and femur (n=2). The hand and the sacrum were implicated in one patient each.

Only two patients had the diagnosis considered in the first visit to the emergency department (ED), while in the majority it was admitted at the second ED visit (n=6) and two at the third. AO was confirmed after 12.5 ± 12 days ENT#091;2-32ENT#093; of symptom onset. After admission, apyrexy was achieved on day 2.4 ± 1 ENT#091;1-4ENT#093;. Resolution of local signs of inflammation and impaired function were seen on day 7.1 ± 2.3 ENT#091;3-13ENT#093;.

Eight patients were submitted to a radiography of the affected location at admission and only two showed alterations. Eight performed a magnetic resonance imaging (MRI), seven of which presented suggestive signs of AO (Fig. 1). Three of the five patients who were submitted to computerized tomography (CT) scan exhibited AO features (Fig. 2). Two patients performed bone scintigraphy, which showed abnormalities consistent with AO (Fig. 3).

Figure 1: Coronal MRI T1-weithed shows a high signal intensity in the proximal right tibia with diffuse low-signal consistent with edema of surrounding soft tissues.  

Figure 2: Left femur CT - cortical lytic lesion in medial third diaphysis. 

Figure 3: Scintigraphy - Increased osteoblastic activity resulting in increased levels of radiotracer uptake in the distal extremity of right tibia consistent with the osteoarticular infection suspection. 

At admission, white blood cell count (WBC), C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) were evaluated in all patients. Mean WBC was 10880 ± 3421/μL ENT#091;6900-18100ENT#093;. Five had WBC of 12000/μL or less. Mean CRP level was 4.57 ± 3.7 mg/dL ENT#091;0.5-11ENT#093; and two had a negative CRP (<0.5 mg/dL). Eight had a high ESR level at admission (>20 mm/hour) with a mean value of 41.7 ± 23.9 mm/hour ENT#091;4-85ENT#093;. During the first six to ten days after admission, ESR levels decreased in all but one and normalized in three (<20 mm/hour). All presented a drop in CRP levels after the first six to ten days, reaching normal ranges in three (Table 1).

Table 1: Evolution of inflammatory markers in the first week of after the diagnosis (6-10 days). 

Patient At admission Evolution
CRP (mg/dL) ESR (mm/hour) Days later CRP (mg/dL) ESR (mm/hour)
1 0.5 4 7 0.5 -
2 3.67 69 - - -
3 2.23 11 7 1.21 -
4 2.26 35 8 0.5 8
5 7.88 35 10 0.5 12
6 5.37 30 6 2.22 15
7 2.07 38 9 0.5 38
8 11 63 7 0.68 43
9 0.5 85 7 0.5 68
10 10.22 47 7 3.38 54

Blood cultures were performed in all patients with a rate of 40% positivity, identifying S. aureus (n=3) and S. pyogenes (n=1). Antimicrobial susceptibility tests didn’t detect methicillin-resistant S. aureus (MRSA). Only one patient was submitted to surgical drainage. Salmonella enteritidis was isolated from a bone abscess. A PCR test from an oropharyngeal swab was performed in a 20-month-old child, with identification of K. kingae. Considering the negative cultures for other microorganisms, a K. kingae AO was assumed in this case.

Empiric parenteral antibiotherapy was initiated with flucloxacillin in most of the cases (n=7). Other chosen antibiotics were ceftriaxone (n=2), cefuroxime (n=2), clindamycin (n=3) and gentamicin (n=1). Parenteral treatment was performed for 14.7 ± 6.2 days ENT#091;8-20ENT#093;. Patients were discharged 17.1 ± 8.2 days after admission. Oral antibiotics were flucloxacillin (n=6), amoxicillin and clavulanic acid (n=2), amoxicillin (n=1) and cefuroxime (n=1), taken for an average of 3.9 ± 0.9 weeks ENT#091;2-5ENT#093;.

The follow-up period was 8.3 ± 5.2 months ENT#091;1-17ENT#093; in eight patients. Two had several follow-up orthopedic appointments for more than one year until the present date. Two cases evolved to local complications - tenosynovitis and bone abscess requiring surgical drainage -, and one progressed to chronic recurrent multifocal osteomyelitis. Only the patient who exhibited tenosynovitis had already completed follow-up.

Discussion

AO was more prevalent in boys and the lower limb was the most affected, as described in the literature.1,6,8 A significant percentage involved children under five years of age. In the majority the cases, AO was only considered after a second visit to the ED, reinforcing its diagnostic challenge.12 Symptom onset is often insidious and clinical manifestations may be scarce.3,6,8 The classic triad of fever, pain and signs of inflammation is frequently absent and lack of specific clinical, radiological and laboratorial features delays diagnosis and treatment.12 The clinical presentation of AO is typically local pain, reported by all patients in our study; and reduced function of the affected limb or structure, which was also in accordance with our reports. In fact, all limb affected patients presented with limping or inability to walk. Other signs of inflammation such as erythema and edema were seen in less than half.

Despite the mentioned risk factors potentially related to AO, all the children were previously healthy. Bacteria can enter the bone by hematogenous route from a distant source of infection, contiguous spread from surrounding tissue and joints or direct inoculation from trauma or surgery.13 Direct recent trauma was reported by 50%, in accordance with the literature. Nevertheless, due to a high incidence of trauma in the pediatric population, its association with AO is questionable.12 In the child bitten by a dog, a direct microorganism inoculation is probable. No other possible risk factors were identified.

At admission, a radiography should always be performed to exclude other bone lesions, namely fractures or tumors.3,5,6,8 Bone destruction is not apparent in plain radiographs until the seventh to tenth day of infection,8,12,14 the time required to a sustained demineralization by inflammatory osteoclastic activity.5 In this study, AO diagnostic imaging was achieved on average by the 12th day after disease onset, and as expected, most radiographs were normal at admission. A CT scan was performed in five patients and was unremarkable in two of them. CT may be useful in identifying bone destruction and soft tissue assessment, but the gold standard is the MRI scan, which enabled the diagnosis in almost all of our patients.1,3,4,6 Initial MRI changes can be present within two to five days after disease onset and it also allows the identification of extraosseous manifestations or complications.1,3 Prior to the emergence of MRI, scintigraphy was the recommended imaging study.15 Leonard P Connollyet al concluded that this imaging strategy remains highly effective, especially if symptoms are poorly localized or occult pelvic AO is suspected.15 Scintigraphy was done in two patients and led to the diagnosis in one of them, after unremarkable radiograph and MRI scan. The other scintigraphy was performed to complete the study of a sacrum AO.

Before antibiotic therapy, blood cultures and, if indicated, bone biopsy/joint fluid samples and antibiotic sensitivity tests should always be performed.3,6 According to the literature, blood cultures are positive in 10%-40% of the cases and bone biopsy/joint fluid cultures in approximately 50%.7 Our rate of blood culture positivity 40%, similar to what is described.3 MRSA has become common in many countries, covering for 30%-40% of osteoarticular infections in children according to a United States study.3 Nevertheless, none has been identified in our population. There is lack of data concerning its prevalence in Portugal. Other AO agents include S. pyogenes, especially as a complication of varicella infection. Recent studies showed K. kingae to be an important causative agent under four years of age.9,10 Samara et al found this pathogen to be responsible for 51% of osteoarticular infections in Geneva’s pediatric population after extensive use of nucleic acid amplification assays.9 Before that, in their cohort of 129 children with AO, a microorganism identification was possible in 76 cases (59.4%), with only one K. kingae. It is important to highlight that a significant statistical difference was only identified in the group of 6 to 48 months. More recently, a Morocco’s study revealed that K. kingae was the leading cause (58.7%) of culture-negative AO in children under 10 years old, mainly between 6 months and 5 years old.16 AO caused by this agent tends to have a more benign clinical evolution, presenting with fever in less than 15% and normal CRP levels in 39%, due to its mild clinical and biological inflammatory response to infection.3,12 Invasive K. kingae disease has been related to herpes simplex stomatitis, hand-foot-mouth disease and varicella and human rhinovirus infections. The importance of the PCR assay in identification of fastidious species, such as K. kingae, should be emphasized. In a highly suspected AO case with negative conventional cultures, PCR-positive oropharyngeal swabs have a positive predictive value of 91% for detection of K. kingae.9,10 In our study, a presumptive diagnosis was assumed in an afebrile 20-month-old with a negative PCR level. Salmonella is rare cause of AO in the absence of risk factors, mainly hemoglobinopathies. In a previously healthy seven-year-old with a complicated AO, Salmonella enteritidis was isolated from pus. No history of recent gastrointestinal infection was reported. After culture collection, empiric broad-spectrum parenteral antibiotherapy is warranted.5 Antibiotic choice is determined by the most likely involved pathogens taking into consideration multiple factors, including: child’s age and comorbidities, microorganism prevalence in the community, regional bacterial susceptibility patterns and circumstances around infection onset.8S. aureus is the most frequent pathogen responsible for AO in older children so, in regions where MRSA has not emerged, semisynthetic penicillin, as flucloxacillin, or first generation cephalosporins are recommended.5 As described earlier, K. kingae should always be considered in children under four years-old, particularly if with insidious onset. There is lack of consensus regarding specific treatment of K. kingae AO. Some authors suggest amoxicillin with clavulanic acid or cefazolin while others indicate ceftriaxone or cefuroxime.17,18K. kingae is generally susceptible to beta-lactams alone, but the minimal inhibitory concentrations of these antibiotics are elevated.19 Treatment of neonatal AO should have a broader antibiotic spectrum due to the increased probability of gram-negative bacillary infection.5 In our study, flucloxacillin was the main choice.

On average, parenteral treatment was taken for 14.7 days, followed by 3.9 weeks of oral antibiotic therapy. Recently, a significant reduction in antibiotherapy duration has been proposed, mainly by shortening the initial parenteral phase to less than a week in uncomplicated cases with clinical and laboratorial improvement and typical causative agents.6,20,21 Recommendations advocate a total antibiotic therapy duration of at least four weeks in healthy children.5,8 Nevertheless, in the neonatal population, complicated cases or those caused by unusual or resistant microorganisms, such as Salmonella, a longer regimen is recommended.21

Complications are more frequently observed in MRSA infections when compared to other organisms5 and generally result from invasion of surrounding tissues, as in arthritis, tenosynovitis, subperiosteal and intraosseous abscess; or sequestrum.1,5,6,8 Surgical approach is indicated in those cases.5 More severe complications include deep vein thrombosis, septic pulmonary emboli and disseminated infection with multiorgan failure.5 Two patients presented with local complications, namely tenosynovitis and a bone abscess, that was submitted to surgical drainage.

Due to AO lack of specificity regarding clinical presentation, as well as laboratorial and radiological features, a high index of suspicion and close monitoring of clinical evolution are essential to establish an early diagnosis.8

Take Home Messages

1. AO is an invasive bacterial disease preferentially affecting male children under five years-old;

2. The clinical hallmark of osteomyelitis is localized pain and impaired function;

3. A normal radiography at admission does not exclude diagnosis because of late bone destruction;

4. The gold standard for AO diagnosis is magnetic resonance imaging;

5. Empirical antibiotic therapy should be initiated as soon as possible by parenteral route and maintained for four to six weeks. The switch to oral route should be performed towards clinical and laboratory improvement.

References

1. Edgington, Jon; Shirley, Eric; Skaggs D. Osteomyelitis - Pediatric ENT#091;homepage on the InternetENT#093;. ENT#091;Accessed September 2021ENT#093;. Available from: Available from: https://www.orthobullets.com/pediatrics/4031/osteomyelitis--pediatric . [ Links ]

2. Neves Cassiano, Manuel (Orthopedic Pediatric Service, Hospital Cuf Descobertas P. Infecções ósseas, articulares e musculares em crianças. Pedipedia.org. ENT#091;Accessed May 2020ENT#093;. Available from: Available from: https://pedipedia.org/artigo-profissional/infeccoes-osseas-articulares-e-musculares-em-criancas . [ Links ]

3. Thakolkaran N, Shetty AK. Acute Hematogenous Osteomyelitis in Children. Ochsner J. 2019;19:116-22. doi: 10.31486/toj.18.0138. [ Links ]

4. Popescu B, Tevanov I, Carp M, Ulici A. Acute hematogenous osteomyelitis in pediatric patients: epidemiology and risk factors of a poor outcome. J Int Med Res. 2020;48: 300060520910889. doi: 10.1177/0300060520910889. [ Links ]

5. Conrad DA. Acute hematogenous osteomyelitis. Pediatr Rev. 2010;31:464-71. doi: 10.1542/pir.31-11-464.6. [ Links ]

6. Loza Rararcsm. Artritis séptica y osteomielitis. In: Manual de Diagnóstico y Terapéutica En Pediatría.6a ed. São Paulo: Editorial Medica Panamericana; 2017. p.1479-84. [ Links ]

7. Pääkkönen M, Peltola H. Acute osteomyelitis in children. N Engl J Med. 2014;370:1365-6. doi: 10.1056/NEJMc1402234. [ Links ]

8. Krogstag P. Hematogeneous osteomyelitis in children. Up To Date. ENT#091;Accessed May 2020ENT#093;. Available from: Available from: https://www.uptodate.com/contents/hematogenous-osteomyelitis-in-children-management . [ Links ]

9. Samara E, Spyropoulou V, Tabard-Fougère A, Merlini L, Valaikaite R, Dhouib A, et al. Kingella kingae and Osteoarticular Infections. Pediatrics. 2019;144:e20191509. doi: 10.1542/peds.2019-1509. [ Links ]

10. Wong M, Williams N, Cooper C. Systematic Review of Kingella kingae Musculoskeletal Infection in Children: Epidemiology, Impact and Management Strategies. Pediatr Heal Med Ther. 2020;11:73-84. doi: 10.2147/phmt.s217475. [ Links ]

11. Castellazzi L, Mantero M, Esposito S. Update on the Management of Pediatric Acute Osteomyelitis and Septic Arthritis. Int J Mol Sci. 2016;17:855. doi: 10.3390/ijms17060855. [ Links ]

12. Boccuzzi E, Buonsenso D, Ferro V, Raucci U, Reale A, Piga S, et al. The Osteoarticular Infection in a Pediatric Emergency Setting: A Challenging Diagnosis. Pediatr Emerg Care. 2020;36:e108-e114. doi: 10.1097/PEC.0000000000002045. [ Links ]

13. Momodu II SV. Osteomyelitis. In: StatPearls ENT#091;InternetENT#093;. Treasure Island (FL): StatPearls; 2020. [ Links ]

14. Riise ØR, Kirkhus E, Handeland KS, Flatø B, Reiseter T, Cvancarova M, et al. Childhood osteomyelitis-incidence and differentiation from other acute onset musculoskeletal features in a population-based study. BMC Pediatr. 2008 20;8:45. doi: 10.1186/1471-2431-8-45. [ Links ]

15. Connolly LP, Connolly SA, Drubach LA, Jaramillo D, Treves ST. Acute hematogenous osteomyelitis of children: Assessment of skeletal scintigraphy-based diagnosis in the era of MRI. J Nucl Med. 2002;43:1310-6. [ Links ]

16. Moutaouakkil K, Oumokhtar B, Abdellaoui H, El Fakir S, Arhoune B, Mahmoud M, et al. First report of Kingella kingae diagnosed in pediatric bone and joint infections in Morocco. BMC Infect Dis. 2021;21:1-6. doi: 10.1186/s12879-021-06361-8. [ Links ]

17. Webb R, Wilson E, Williams G, Voss L, Stott S, Crawford H et al. Osteomyelitis: Starship clinical guidelines. Starship Child Health. New Zeland, March 2021 ENT#091;Accessed Out 2021ENT#093;. Available from: Available from: https://starship.org.nz/guidelines/osteomyelitis/ . [ Links ]

18. Woods CR, Bradley JS, Chatterjee A, Copley LA, Robinson J, Kronman MP, et al. Clinical Practice Guideline by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America: 2021 Guideline on Diagnosis and Management of Acute Hematogenous Osteomyelitis in Pediatrics. J Pediatric Infect Dis Soc. 2021;10:801-44. doi: 10.1093/jpids/piab027. [ Links ]

19. Yagupsky P. Review highlights the latest research in Kingella kingae and stresses that molecular tests are required for diagnosis. Acta Paediatr Int J Paediatr. 2021;110:1750-8. doi: 10.1111/apa.15773. [ Links ]

20. Queensland Children's Hospital. Paediatric Bone and Joint Infection Management ENT#091;accessed Out 2021ENT#093;. Available from: Available from: https://www.childrens.health.qld.gov.au/wp-content/uploads/PDF/ams/guide-paed-bone-jnt.pdf . [ Links ]

21. Saavedra-Lozano J, Falup-Pecurariu O, Faust SN, Girschick H, Hartwig N, Kaplan S, et al. Bone and Joint Infections. Pediatr Infect Dis J. 2017;36:788-99. doi: 10.1097/INF.0000000000001635. [ Links ]

Responsabilidades Éticas

Fontes de Financiamento: Não existiram fontes externas de financiamento para a realização deste artigo

Confidencialidade dos Dados: Os autores declaram ter seguido os protocolos da sua instituição acerca da publicação dos dados de doentes

Proteção de Pessoas e Animais: Os autores declaram que os procedimentos seguidos estavam de acordo com os regulamentos estabelecidos pelos responsáveis da Comissão de Investigação Clínica e Ética e de acordo com a Declaração de Helsínquia revista em 2013 e da Associação Médica Mundial

Proveniência e Revisão por Pares: Não comissionado; revisão externa por pares

Ethical Disclosures

Financing Support: This work has not received any contribution, grant or scholarship

Confidentiality of Data: The authors declare that they have followed the protocols of their work center on the publication of data from patients

Protection of Human and Animal Subjects: The authors declare that the procedures followed were in accordance with the regulations of the relevant clinical research ethics committee and with those of the Code of Ethics of the World Medical Association (Declaration of Helsinki as revised in 2013)

Provenance and Peer Review: Not commissioned; externally peer reviewed

Received: September 03, 2021; Accepted: November 17, 2021; Published: December 31, 2021

Mafalda Casinhas Santos ENT#091;mafaldacasinhassantos@gmail.comENT#093; Hospital Vila Franca de Xira - Estrada Carlos Lima Costa Nº2, 2600-009 Vila Franca de Xira, Portugal ORCID iD: 0000-0001-7082-9373

Conflitos de Interesse:

Os autores declaram a inexistência de conflitos de interesse na realização do presente trabalho.

Conflicts of Interest:

The authors have no conflicts of interest to declare.

Creative Commons License This is an open-access article distributed under the terms of the Creative Commons Attribution License